Cyclopharm Limited Revises AGM Date and Director Nomination Deadline
Cyclopharm Limited has revised the date for its Annual General Meeting to May 30, 2025, with director elections on the agenda. The new deadline for director nominations is April 9, 2025. This announcement, approved by CEO James McBrayer, is crucial for stakeholders as it outlines the company's governance timeline. Cyclopharm, an ASX-listed radiopharmaceutical company, focuses on improving patient care through its product, Technegas®, used for lung imaging. The company has a market cap of A$131.1M and a year-to-date price performance of -29.43%.
Tip Ranks·